borderline significanceP =0.050
Patients presenting with pre-ablative Tg<1.0 ng/mL were more frequent in Group A with a borderline significance ( P =0.050).
Patients presenting with pre-ablative Tg<1.0 ng/mL were more frequent in Group A with a borderline significance ( P =0.050).